iLoF is a pioneering healthtech company dedicated to revolutionizing personalized medicine through advanced AI and photonics. Recognized by CB Insights and the Financial Times as one of the most promising digital health companies globally, iLoF is developing an AI-powered platform that aims to democratize access to personalized medicine for patients with complex diseases. With a proprietary optical fingerprint library of disease biomarkers, iLoF offers faster and more affordable patient screening and stratification, significantly reducing costs and time while enhancing the patient experience. Supported by prestigious institutions like Microsoft Ventures and Oxford University, iLoF is focused on addressing major health challenges, including Alzheimer's, digestive cancer, stroke, and infectious diseases. The team, comprised of scientists, entrepreneurs, and inventors based in Oxford and Porto, fosters a culture of kindness, collaboration, and innovation, striving to make a meaningful impact in healthcare.